Matzav · Nov 9, 2026
Matzav — photo status
*NEW VISION LOSS WARNING: FDA Flags Rare Risk of Permanent Blindness Linked to Ozempic, Wegovy and Mounjaro* The U.S. Food and Drug Administration is requiring new safety warnings for widely prescribed diabetes and weight-loss medications, including Ozempic, Wegovy, Mounjaro and Zepbound, following findings suggesting a possible association between the drugs and a rare eye condition that can cause sudden, potentially permanent vision loss. *READ MORE*👉👉 https://matzav.com/new-vision-loss-warning-fda-flags-rare-risk-of-permanent-blindness-linked-to-ozempic-wegovy-and-mounjaro/ --- 📲 *Join the Matzav.com WhatsApp Family!* 🗞️ https://wa.link/8bhhfl
More from Matzav
- MatzavNov 13, 2026 · 40 YESHIVA BOCHURIM BEHIND BARS: Detainees to Spend Shabbos

- MatzavNov 13, 2026 · GADOL HADOR IN ASBURY PARK: Rav Moshe Hillel Hirsch to Lead

- MatzavNov 13, 2026 · KASHRUS UPHEAVAL IN RECHOVOT: Rav Rubin Warns Against Relyin

- MatzavNov 13, 2026 · MAJOR GOP UPSET: Trump Ally Lauren Boebert Ousted as Democra

- MatzavNov 13, 2026 · NEW TERROR CHARGE: Suspect in Attempted Assassination of Tru

- MatzavNov 13, 2026 · PRESSURE ON TRUMP: Mossad Chief Holds Washington Talks as Ne
